Randox Health, the leading UK diagnostics company is continuing its clinic expansion in the capital, opening its new Canary Wharf clinic on 17 April 2023. This will be London’s 9th Randox Health clinic, bringing the world’s most advanced and personalised Health Programme directly to the consumer. Canary Wharf is the latest in a national roll-out programme, with over 20 Randox Health clinics operating in the UK, with many more planned.
Randox’s High Street investment in personalised healthcare and diagnostic testing follows the company’s success in delivering 25 million Covid-19 PCR tests during the pandemic emergency.
As well as its condition-specific tests, Randox clinics also offer a new range of comprehensive diagnostic programmes, including the ‘EveryMan’ and ‘EveryWoman’ 12-month programmes. These enable up to 150 data points linked to key health areas to be measured during each visit with a personalised health plan summarising results provided. Repeat tests will be arranged six months after the initial test, included in the testing programme prices, which start at £295 per person.
Its growing network of clinics provide easy access for millions to a new Randox range of diagnostic tests, including for fertility, vitamin deficiencies, hormone imbalances, allergies and key health concerns including heart, liver and kidney conditions. These tests are available from £49 and will increase the accessibility of real, affordable and preventative healthcare through Randox’s innovative combination of technology and science.
To complement its range of preventative health programmes Randox Health have partnered with Reviv, to launch an exclusive range of IV therapies and booster shots designed to give clients the vitamins, nutrients, and minerals their body needs to improve hydration, energy levels, immunity and the appearance of skin, hair, & nails.
With over 40 years of diagnostic experience Randox is globally recognised as being at the forefront of diagnostic capability.
David Ferguson, Chief Operating Officer of Randox Health said: “Randox believes that in harnessing the capabilities of innovative diagnostics we can help the shift away from the traditional model of sickness management to a new era of truly preventative healthcare.
“Having a regular review of personalised health data is vital to understanding and maintaining good health. Access to regular health screening will allow clients to actively take control of their health to prevent or delay disease.
“This will benefit individuals and society by improving patient outcomes and considerably reducing the burden on our vital and hard-pressed clinical services.”
Prebooking at Randox Health Canary Wharf is now available on the Randox Health website.
Location
Randox Health – Canary Wharf
Street Level 0
Cabot Place
Canary Wharf
London
E14 4QT
ENDS
For further information, please contact:
Ian Monk
T: +44 (0) 7970 026 072
ian.monk@woburnpartners.com
Notes to Editors
About Randox Health
Established in 1982, Randox is the largest healthcare diagnostics company from the UK and Ireland.
Undertaking research, development, manufacture and distribution of innovative laboratory tests and analysers, Randox provides 15% of all worldwide cholesterol tests and 10% of all clinical chemistry tests. More than 5% of the world’s population (over 370 million people) receive medical diagnosis using Randox products each year.
In 2016, Randox Health opened its first diagnostics clinic in Crumlin.
Randox Health focuses on the provision of timely and accurate testing to identify risk to health, improve clinical diagnoses and promote preventative healthcare; aiming to achieve better healthcare outcomes whilst reducing the burden on clinical services.
In early 2020 Randox recognised the threat from COVID-19 and quickly developed a test to accurately identify the virus. Testing at scale commenced within weeks to support the UK’s National Testing Programme and private clients. Randox has processed more than 25 million gold-standard PCR tests for the National Testing Programme and private COVID testing for travel.
Randox High Street Clinics are currently at the following locations:
- St Paul’s, London
- Great Portland Street, London
- Kensington, London
- Fulham, London
- Chiswick, London
- Chelsea, London
- Croydon, London
- Westfield Stratford City, London
- Liverpool
- Chichester
- Birmingham
- Manchester Trafford Centre
- Glasgow
- Edinburgh
- Belfast
- Holywood, Northern Ireland
- Derry/Londonderry, Northern Ireland
- Crumlin, Northern Ireland
Randox Health is clear that better diagnostics are unquestionably critical to future improvements within healthcare and is committed to remaining at the forefront of that field.
About Canary Wharf Group:
Canary Wharf Group (CWG) is the developer of the largest urban regeneration project in Europe. CWG develops, manages and currently owns interests in approximately 9 million square feet of mixed-use space and over 1,100 Build to Rent apartments.
CWG is a sustainable developer in the UK and also excels operationally as it has purchased 100% electricity from renewable sources since 2012 and sent zero waste to landfill since 2009.
CWG has created a 24/7 city where people can live, work and thrive on the Canary Wharf estate and enjoy all the benefits: great transport links, access to green spaces and waterside living; and a wide range of amenities including an award-winning arts and events programme. Canary Wharf’s retail offering comprises over 300 shops, including grocery stores, pharmacies, health clubs, bars and restaurants, all within 15 minutes’ walk.
The Company’s current £2bn construction activity and pipeline includes more than 500k square feet NIA of commercial properties and over 2,300 new homes for sale and rent.
www.canarywharf.com
LinkedIn: @CanaryWharfGroup
Instagram: @canarywharflondon /@canarywharfworks
TikTok: @canarywharflondon
Twitter: @CanaryWharfGrp / @Level39CW / @Wood_Wharf